With over 18 years of experience in the biopharmaceutical industry, my tenure at Bristol-Myers Squibb as a Senior Scientist has been marked by a deep commitment to GLP laboratory excellence, adherence to U.S. Title 21 CFR Part 11 regulation, and support of FDA submissions. Mastery in Visio and Office 365 has enabled the streamlining of processes to maintain rigorous data integrity assessments for processes and systems. My expertise in toxicology, honed over the years at both Bristol-Myers Squibb and Huntingdon Life Sciences, from both the laboratory setting through the submission process.